Kaplan Fox Encourages Investors of Endava plc (NYSE: DAVA) to Contact the Firm to Learn About Their Legal Rights

A securities class action has been filed against Endava over alleged misleading disclosures concerning the accounting treatment of customer and supplier agreements. The allegations follow Endava’s September 21 disclosure that CFO Mark Thurston was placed on administrative leave during an internal accounting investigation; its ADSs fell $0.68, or more than 24%, to $2.11 on September 22. Investors who acquired shares between September 4, 2025 and September 21, 2026 have until November 30, 2026 to seek lead-plaintiff status.

Analysis

The litigation notice itself is not incremental fundamental information; the investable issue is whether the investigation produces a restatement, delayed filing, qualified audit opinion, or a reclassification of revenue/cost of sales. Customer-supplier agreement accounting can alter reported growth and gross margin simultaneously, making consensus EBITDA estimates unreliable even if cash receipts are unchanged. At a distressed equity price, the next 1-3 month valuation driver is not the lawsuit’s eventual outcome but the scope and duration of the internal review and any financing/audit disruption.

DAVA’s digital-engineering peers EPAM, Globant (GLOB), and EXLService (EXLS) should not receive a direct read-through absent evidence that the arrangements reflect an industry-wide principal-versus-agent or rebate-recognition practice. The more likely second-order effect is company-specific: customers may defer discretionary transformation projects while management attention is consumed by remediation, worsening utilization and creating negative operating leverage. A delayed earnings release or withdrawal of guidance would likely matter more than a further legal headline because it removes the market’s ability to underwrite normalized margins.

Consensus may overfocus on litigation damages and underprice the binary accounting-risk tail. Conversely, after a severe one-day repricing, shorting solely on additional plaintiff-firm announcements is unattractive: these releases are mechanically follow-on and can create no new information. The bearish thesis is falsified by a timely independent-review conclusion with no material restatement, a clean auditor position, and guidance that demonstrates stable client retention and utilization; without those data, DAVA is a watch-list special situation rather than a high-conviction directional position.

Key Decisions for Investors

• Do not initiate a fresh DAVA short on this law-firm release. Reassess only if the company delays a statutory filing, withdraws guidance, discloses a material error/restatement, or reports auditor disagreement; these events would establish a tradable fundamental catalyst over the next 30-90 days.
• For existing DAVA longs, reduce or hedge exposure until the investigation scope, cash impact, and audit timetable are disclosed. Treat any rebound driven solely by litigation exhaustion as an opportunity to lower risk, not confirmation that accounting exposure is resolved.
• Use a relative-quality screen rather than a sector short: consider long EXLS or GLOB versus DAVA only after confirming that their revenue-recognition disclosures and customer-concentration profiles do not contain analogous supplier pass-through arrangements. The pair targets DAVA-specific multiple compression while limiting broad IT-services demand risk over 1-3 months.
• Set event alerts for an earnings-date change, 6-K/20-F filing delay, auditor language, CFO replacement, and revised revenue/gross-margin history. A clean resolution can drive a sharp short-covering rally from depressed levels; a material restatement or liquidity warning warrants reassessing for downside exposure.